corporate_event

Insmed Sets Two Investor Conference Slots in London, Florida

Image
Insmed Sets Two Investor Conference Slots in London, Florida

Bridgewater – November 04, 2026 -- Insmed Incorporated (Nasdaq: INSM) will put management in front of investors at two healthcare conferences within a span of 15 days, starting November 16 in London.

Insmed management to present at Jefferies in London on November 16

The company will appear at the Jefferies Global Healthcare Conference in London on Monday, November 16, 2026, at 9:00 a.m. ET.

Evercore session in Coral Gables is set for December 1

Management will then present at the Evercore 9th Annual Healthcare Conference in Coral Gables, Florida, on Tuesday, December 1, 2026, at 9:10 a.m. ET.

Both presentations will be webcast live and archived for 30 days

Both events will be webcast live through the investor relations section of Insmed's website. Each webcast will remain archived for 30 days after the live event ends.

Flex LNG CFO Presents at Pareto Energy Conference in Oslo

Hamilton – October 29, 2026 -- Flex LNG Ltd (NYSE: FLNG) is presenting at Pareto Securities' 33rd Annual Energy Conference in Oslo today, with Chief Financial Officer Knut Traaholt delivering the presentation.

Flex LNG operates 13 LNG carriers with two-stroke propulsion

The Bermuda-based shipping company runs thirteen LNG carriers on the water. All vessels use latest-generation two-stroke propulsion, in MEGI and X-DF configurations.

Flex LNG says these engines deliver significant improvements in fuel efficiency, and therefore a lower carbon footprint, compared with older steam and four-stroke propelled ships.

Flex LNG publishes the presentation on its website

The company has attached the presentation to its announcement and posted it on its corporate website. Investor inquiries go to Traaholt in his role as CFO of Flex LNG Management AS.

REGENXBIO Sets Oct. 20 Investor Event Before Wet AMD Pivotal Data

Image
REGENXBIO Sets Oct. 20 Investor Event Before Wet AMD Pivotal Data

Rockville, Md. – October 13, 2026 -- REGENXBIO Inc. (Nasdaq: RGNX) will host a three-hour investor event on October 13, 2026 to review its wet age-related macular degeneration (wet AMD) gene therapy program, with topline pivotal data anticipated in the fourth quarter of 2026.

Event runs 1:00 p.m. to 4:00 p.m. ET in New York and online

The session will be held in person in New York and streamed by webcast. It will cover the clinical program for surabgene lomparvovec (sura-vec, ABBV-RGX-314), which REGENXBIO is developing in collaboration with AbbVie.

Management and five retina specialists to address commercial readiness

REGENXBIO management and retina specialists will discuss the treatment landscape, unmet need, the ATMOSPHERE and ASCENT pivotal trials, and the commercial readiness of sura-vec in wet AMD.

Five key opinion leaders are scheduled to appear:

Protalix CFO to Present at H.C. Wainwright, Morgan Stanley Healthcare Conferences

Image
Protalix CFO to Present at H.C. Wainwright, Morgan Stanley Healthcare Conferences

Carmiel, Israel – September 13, 2026 -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) confirmed that Chief Financial Officer Gilad Mamlok will represent the company at two investor conferences in New York City this month.

Mamlok addresses H.C. Wainwright's 28th Annual Global Investment Conference on September 14

The presentation is scheduled for 2:00 p.m. EDT during the three-day event running September 14-16, 2026.

Morgan Stanley's 24th Annual Global Healthcare Conference hosts a fireside chat on September 16

The session is set for 1:05 p.m. EDT and will be streamed via a live audio webcast, with an archived replay available afterward on Protalix's investor relations site.

REGENXBIO to Present at Baird, Morgan Stanley Healthcare Conferences

Image
REGENXBIO to Present at Baird, Morgan Stanley Healthcare Conferences

Rockville, Maryland – September 12, 2026 -- REGENXBIO Inc. (Nasdaq: RGNX) will hold fireside chats at two major investor healthcare conferences in New York this month.

REGENXBIO confirms back-to-back fireside chats on September 15 and 16

The gene therapy company will participate in the Baird 2026 Global Healthcare Conference on Tuesday, September 15 at 8:30 a.m. ET, followed by the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16 at 8:30 a.m. ET. Both sessions will take place in New York, NY.